1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial
    Meeting Abstract

    Li, B. T.; Li, T.; Johnson, M. L.; Waqar, S. N.; Zhu, V. W.; Ou, S. H. I.; Lin, J. J.; Wang, D.; Shapiro, G.; Wang, J. S. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping
    Meeting Abstract

    Le, X.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Garassino, M. C.; Mazieres, J.; Ramirez, S. V.; Senellart, H.; Van Meerbeeck, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Lee, C. H.; Wan, Y.; Smith, A. D.; Xie, R.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population
    Meeting Abstract

    Kummar, S.; Van Tilburg, C. M.; Albert, C. M.; Berlin, J.; Farago, A. F.; McDermott, R. S.; Bielack, S. S.; Doz, F. P.; DuBois, S. G.; Lassen, U. N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Progression-free survival estimates in non-small cell lung cancer when RECIST is unavailable: Project GENIE's integration of genomic, therapeutic and phenomic data
    Meeting Abstract

    Lavery, J. A.; Panageas, K.; LeNoue-Newton, M.; Sweeney, S.; Sheffler-Collins, S.; Rudolph, J. E.; Rizvi, H.; Schultz, N.; Lepisto, E. M.; Kehl, K. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
    Meeting Abstract

    Khan, S.; Lutzky, J.; Shoushtari, A. N.; Jeter, J. M.; Chiuzan, C.; Sender, N.; Blumberg, L. E.; Nesson, A.; Singh-Kandah, S. V.; Hernandez, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC)
    Meeting Abstract

    Kelley, R. K.; Sangro, B.; Harris, W. P.; Ikeda, M.; Okusaka, T.; Kang, Y. K.; Qin, S.; Tai, W. M. D.; Lim, H. Y.; Yau, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save